down arrow

Ginkgo Bioworks Holdings, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US37611X1000
USD
8.24
0.00 (0.00%)

Dec 18

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Azenta, Inc.
The Ensign Group, Inc.
Amedisys, Inc.
Option Care Health, Inc.
Encompass Health Corp.
Teladoc Health, Inc.
Acadia Healthcare Co., Inc.
Guardant Health, Inc.
Agilon Health, Inc.
Ginkgo Bioworks Holdings, Inc.
DaVita, Inc.
Why is Ginkgo Bioworks Holdings, Inc. ?
1
Poor long term growth as Operating profit has grown by an annual rate -274.96% of over the last 5 years
2
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -7.48%, its profits have risen by 44.7%
3
Underperformed the market in the last 1 year
  • Even though the market (S&P 500) has generated returns of 14.11% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -7.48% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Ginkgo Bioworks Holdings, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Ginkgo Bioworks Holdings, Inc.
-6.26%
-0.49
105.05%
S&P 500
11.09%
0.70
20.15%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-13.46%
EBIT Growth (5y)
-274.96%
EBIT to Interest (avg)
-826.33
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.81
Sales to Capital Employed (avg)
0.27
Tax Ratio
0.09%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
86.64%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.69
EV to EBIT
0.21
EV to EBITDA
0.25
EV to Capital Employed
-0.66
EV to Sales
-0.34
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-60.42%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD -237.71 MM

NET PROFIT(HY)

Higher at USD -152.44 MM

ROCE(HY)

Highest at -43.59%

DEBTORS TURNOVER RATIO(HY)

Highest at 10.99 times

-5What is not working for the Company
NET SALES(Q)

At USD 49.6 MM has Fallen at -16.43%

RAW MATERIAL COST(Y)

Grown by 14.81% (YoY

DEBT-EQUITY RATIO (HY)

Highest at -9.11 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 0 times

Here's what is working for Ginkgo Bioworks Holdings, Inc.
Net Profit
Higher at USD -152.44 MM
than preceding 12 month period ended Jun 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Net Profit
At USD -152.44 MM has Grown at 48.43%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

Operating Cash Flow
Highest at USD -237.71 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Debtors Turnover Ratio
Highest at 10.99 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Ginkgo Bioworks Holdings, Inc.
Net Sales
At USD 49.6 MM has Fallen at -16.43%
over average net sales of the previous four periods of USD 59.35 MM
MOJO Watch
Near term sales trend is very negative

Net Sales (USD MM)

Debt-Equity Ratio
Highest at -9.11 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio
Lowest at 0 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Raw Material Cost
Grown by 14.81% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."